BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17053054)

  • 1. Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays.
    Pfeifer D; Pantic M; Skatulla I; Rawluk J; Kreutz C; Martens UM; Fisch P; Timmer J; Veelken H
    Blood; 2007 Feb; 109(3):1202-10. PubMed ID: 17053054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14.
    Ouillette P; Erba H; Kujawski L; Kaminski M; Shedden K; Malek SN
    Cancer Res; 2008 Feb; 68(4):1012-21. PubMed ID: 18281475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia--a comparative study of four differently designed, high resolution microarray platforms.
    Gunnarsson R; Staaf J; Jansson M; Ottesen AM; Göransson H; Liljedahl U; Ralfkiaer U; Mansouri M; Buhl AM; Smedby KE; Hjalgrim H; Syvänen AC; Borg A; Isaksson A; Jurlander J; Juliusson G; Rosenquist R
    Genes Chromosomes Cancer; 2008 Aug; 47(8):697-711. PubMed ID: 18484635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia.
    Gunnarsson R; Mansouri L; Isaksson A; Göransson H; Cahill N; Jansson M; Rasmussen M; Lundin J; Norin S; Buhl AM; Smedby KE; Hjalgrim H; Karlsson K; Jurlander J; Geisler C; Juliusson G; Rosenquist R
    Haematologica; 2011 Aug; 96(8):1161-9. PubMed ID: 21546498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations.
    Edelmann J; Holzmann K; Miller F; Winkler D; Bühler A; Zenz T; Bullinger L; Kühn MW; Gerhardinger A; Bloehdorn J; Radtke I; Su X; Ma J; Pounds S; Hallek M; Lichter P; Korbel J; Busch R; Mertens D; Downing JR; Stilgenbauer S; Döhner H
    Blood; 2012 Dec; 120(24):4783-94. PubMed ID: 23047824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new method to detect loss of heterozygosity using cohort heterozygosity comparisons.
    Green MR; Jardine P; Wood P; Wellwood J; Lea RA; Marlton P; Griffiths LR
    BMC Cancer; 2010 May; 10():195. PubMed ID: 20462409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays.
    Hagenkord JM; Monzon FA; Kash SF; Lilleberg S; Xie Q; Kant JA
    J Mol Diagn; 2010 Mar; 12(2):184-96. PubMed ID: 20075210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypes.
    Schweighofer CD; Coombes KR; Majewski T; Barron LL; Lerner S; Sargent RL; O'Brien S; Ferrajoli A; Wierda WG; Czerniak BA; Medeiros LJ; Keating MJ; Abruzzo LV
    J Mol Diagn; 2013 Mar; 15(2):196-209. PubMed ID: 23273604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia.
    Ouillette P; Collins R; Shakhan S; Li J; Li C; Shedden K; Malek SN
    Clin Cancer Res; 2011 Nov; 17(21):6778-90. PubMed ID: 21890456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array.
    Toma MI; Grosser M; Herr A; Aust DE; Meye A; Hoefling C; Fuessel S; Wuttig D; Wirth MP; Baretton GB
    Neoplasia; 2008 Jul; 10(7):634-42. PubMed ID: 18592004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia.
    Ouillette P; Collins R; Shakhan S; Li J; Peres E; Kujawski L; Talpaz M; Kaminski M; Li C; Shedden K; Malek SN
    Blood; 2011 Sep; 118(11):3051-61. PubMed ID: 21795749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.
    Lehmann S; Ogawa S; Raynaud SD; Sanada M; Nannya Y; Ticchioni M; Bastard C; Kawamata N; Koeffler HP
    Cancer; 2008 Mar; 112(6):1296-305. PubMed ID: 18246537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia.
    Malek SN
    Oncogene; 2013 Jun; 32(23):2805-17. PubMed ID: 23001040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia.
    Salaverria I; Martín-Garcia D; López C; Clot G; García-Aragonés M; Navarro A; Delgado J; Baumann T; Pinyol M; Martin-Guerrero I; Carrió A; Costa D; Queirós AC; Jayne S; Aymerich M; Villamor N; Colomer D; González M; López-Guillermo A; Campo E; Dyer MJ; Siebert R; Armengol L; Beà S
    Genes Chromosomes Cancer; 2015 Nov; 54(11):668-80. PubMed ID: 26305789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.
    Knight SJ; Yau C; Clifford R; Timbs AT; Sadighi Akha E; Dréau HM; Burns A; Ciria C; Oscier DG; Pettitt AR; Dutton S; Holmes CC; Taylor J; Cazier JB; Schuh A
    Leukemia; 2012 Jul; 26(7):1564-75. PubMed ID: 22258401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoallelic and biallelic deletions of 13q14 in a group of CLL/SLL patients investigated by CGH Haematological Cancer and SNP array (8x60K).
    Grygalewicz B; Woroniecka R; Rygier J; Borkowska K; Rzepecka I; Łukasik M; Budziłowska A; Rymkiewicz G; Błachnio K; Nowakowska B; Bartnik M; Gos M; Pieńkowska-Grela B
    Mol Cytogenet; 2016; 9():1. PubMed ID: 26740820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia.
    Ouillette P; Saiya-Cork K; Seymour E; Li C; Shedden K; Malek SN
    Clin Cancer Res; 2013 Jun; 19(11):2893-904. PubMed ID: 23620403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene dosage effects in chronic lymphocytic leukemia.
    Sellmann L; Scholtysik R; Kreuz M; Cyrull S; Tiacci E; Stanelle J; Carpinteiro A; Nückel H; Boes T; Gesk S; Siebert R; Klein-Hitpass L; Dührsen U; Dürig J; Küppers R
    Cancer Genet Cytogenet; 2010 Dec; 203(2):149-60. PubMed ID: 21156227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Array comparative genomic hybridization analysis identifies recurrent gain of chromosome 2p25.3 involving the ACP1 and MYCN genes in chronic lymphocytic leukemia.
    Ma D; Chen Z; Patel KP; Mishra BM; Yao H; Abruzzo LV; Medeiros LJ; Wierda W; Keating M; Sargent R; Luthra R
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1(Suppl 1):S17-24. PubMed ID: 22035742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel recurrent gain on 20q13 in chronic lymphocytic leukemia by array CGH and gene expression profiling.
    Rodríguez AE; Robledo C; García JL; González M; Gutiérrez NC; Hernández JA; Sandoval V; García de Coca A; Recio I; Risueño A; Martín-Núñez G; García E; Fisac R; Conde J; de Las Rivas J; Hernández JM
    Ann Oncol; 2012 Aug; 23(8):2138-2146. PubMed ID: 22228453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.